STOCK TITAN

Forward Pharma A/S - $FWPAY STOCK NEWS

Welcome to our dedicated page for Forward Pharma A/S news (Ticker: $FWPAY), a resource for investors and traders seeking the latest updates and insights on Forward Pharma A/S stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Forward Pharma A/S's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Forward Pharma A/S's position in the market.

Rhea-AI Summary
Forward Pharma A/S (Forward) announced the termination of the Deposit Agreement, dated October 14, 2014, resulting in the termination of the existing ADR facility effective February 5, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.57%
Tags
none
Forward Pharma A/S

OTC:FWPAY

FWPAY Rankings

FWPAY Stock Data

7.45M
79.22M
2.11%
0.06%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Denmark
Copenhagen K

About FWPAY

forward pharma is a privately held biotechnology company focused on developing novel and improved immunomodulatory compounds for the treatment of psoriasis and other autoimmune and inflammatory disorders. our lead drug candidate, fp 187, is an oral small molecule that has completed clinical phase i. forward pharma a/s was founded in 2005 and is headquartered in copenhagen, denmark, in the heart of medicon valley. since 2007 we are also operating out of a subsidiary, forward pharma gmbh, in leipzig, germany